AKRO logo

Akero Therapeutics (AKRO) Accounts Payable

Annual Accounts Payable

$7.04 M
-$930.00 K-11.67%

December 31, 2023


Summary


Performance

AKRO Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAKRObalance sheetmetrics:

Quarterly Accounts Payable

$25.22 M
+$10.65 M+73.14%

September 30, 2024


Summary


Performance

AKRO Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAKRObalance sheetmetrics:

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

AKRO Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-11.7%+120.2%
3 y3 years+105.3%+271.8%
5 y5 years+412.6%+10000.0%

AKRO Accounts Payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-11.7%+5.0%at high+466.8%
5 y5-year-11.7%+643.2%at high+2563.5%
alltimeall time-11.7%>+9999.0%at high>+9999.0%

Akero Therapeutics Accounts Payable History

DateAnnualQuarterly
Sep 2024
-
$25.22 M(+73.1%)
Jun 2024
-
$14.57 M(+5.7%)
Mar 2024
-
$13.78 M(+95.8%)
Dec 2023
$7.04 M(-11.7%)
$7.04 M(-38.6%)
Sep 2023
-
$11.45 M(+13.2%)
Jun 2023
-
$10.12 M(+43.0%)
Mar 2023
-
$7.08 M(-11.1%)
Dec 2022
$7.97 M(+18.8%)
$7.97 M(+32.6%)
Sep 2022
-
$6.01 M(-12.6%)
Jun 2022
-
$6.88 M(+54.5%)
Mar 2022
-
$4.45 M(-33.6%)
Dec 2021
$6.71 M
$6.71 M(-1.1%)
DateAnnualQuarterly
Sep 2021
-
$6.78 M(+194.1%)
Jun 2021
-
$2.31 M(-49.9%)
Mar 2021
-
$4.61 M(+34.3%)
Dec 2020
$3.43 M(+262.0%)
$3.43 M(-26.1%)
Sep 2020
-
$4.64 M(+82.8%)
Jun 2020
-
$2.54 M(+65.2%)
Mar 2020
-
$1.53 M(+62.1%)
Dec 2019
$947.00 K(-31.0%)
$947.00 K(+918.3%)
Sep 2019
-
$93.00 K(-97.1%)
Jun 2019
-
$3.25 M(+241.2%)
Mar 2019
-
$952.00 K(-30.7%)
Dec 2018
$1.37 M(+2188.3%)
$1.37 M
Dec 2017
$60.00 K
-

FAQ

  • What is Akero Therapeutics annual accounts payable?
  • What is the all time high annual accounts payable for Akero Therapeutics?
  • What is Akero Therapeutics annual accounts payable year-on-year change?
  • What is Akero Therapeutics quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Akero Therapeutics?
  • What is Akero Therapeutics quarterly accounts payable year-on-year change?

What is Akero Therapeutics annual accounts payable?

The current annual accounts payable of AKRO is $7.04 M

What is the all time high annual accounts payable for Akero Therapeutics?

Akero Therapeutics all-time high annual accounts payable is $7.97 M

What is Akero Therapeutics annual accounts payable year-on-year change?

Over the past year, AKRO annual accounts payable has changed by -$930.00 K (-11.67%)

What is Akero Therapeutics quarterly accounts payable?

The current quarterly accounts payable of AKRO is $25.22 M

What is the all time high quarterly accounts payable for Akero Therapeutics?

Akero Therapeutics all-time high quarterly accounts payable is $25.22 M

What is Akero Therapeutics quarterly accounts payable year-on-year change?

Over the past year, AKRO quarterly accounts payable has changed by +$13.77 M (+120.21%)